AwesomeCapital
Wednesday, June 30, 2021
Trauma therapies that are proven to work
›
The building collapse in Surfside, Florida last week killed at least 16 people, and nearly 150 remain unaccounted for, but what will becom...
COVID Vaccines Put to the Test in Essential Workers
›
COVID-19 vaccination with Pfizer or Moderna mRNA vaccines was effective in essential workers, preventing infection and reducing the severi...
CureVac COVID-19 vaccine records only 48% efficacy in final trial readout
›
CureVac said its COVID-19 vaccine was 48% effective in the final analysis of its pivotal mass trial, only marginally better than the 47% r...
Absci Files for IPO
›
Absci Corporation ("Absci"), the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, ...
How CRISPR gene editing will treat diseases in future: Nobel-winning Intellia co-founder Jennifer Doudna
›
Gene-editing technology CRISPR reached a major milestone this past weekend , completing its first systemic delivery as a medicine to a h...
Sellas Life Sciences Reports on Ovarian Cancer Treatment
›
Sellas Life Sciences Group Inc. shares rose premarket Wednesday, after the company said it saw promising updated clinical data and initial...
Mix and match regimen of AZ and Pfizer COVID jabs works well
›
Giving one dose each of AstraZeneca and Pfizer COVID-19 vaccines provides good protection against the SARS-CoV-2 virus, but may be associa...
‹
›
Home
View web version